Current literature shows one case report about a case of non-small cell lung cancer (NSCLC) with EGFR exon 19 deletion mutation, in which osimertinib eradicated the metastasis and prevented the need for radiation therapy (39). This evidence concerns the gene EGFR and non-small cell lung carcinoma.